| Literature DB >> 23759879 |
Marcella Franquesa1, Martin J Hoogduijn, Marlies E Reinders, Elke Eggenhofer, Anja U Engela, Fane K Mensah, Joan Torras, Antonello Pileggi, Cees van Kooten, Bernard Mahon, Oliver Detry, Felix C Popp, Volker Benseler, Federica Casiraghi, Christian Johnson, Janis Ancans, Barbara Fillenberg, Olga delaRosa, Josep M Aran, Marieke Roemeling-van Rhijn, Marieke Roemeling-vanRhijn, Jef Pinxteren, Norberto Perico, Eliana Gotti, Bruno Christ, James Reading, Martino Introna, Robert Deans, Murat Shagidulin, Ramon Farré, Alessandro Rambaldi, Albert Sanchez-Fueyo, Natasha Obermajer, Andrey Pulin, Frank J M F Dor, Isabel Portero-Sanchez, Carla C Baan, Ton J Rabelink, Giuseppe Remuzzi, Michiel G H Betjes, Marc H Dahlke, Josep M Grinyó.
Abstract
The Fourth Expert Meeting of the Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Consortium took place in Barcelona on October 19 and 20, 2012. This meeting focused on the translation of preclinical data into early clinical settings. This position paper highlights the main topics explored on the safety and efficacy of mesenchymal stem cells as a therapeutic agent in solid organ transplantation and emphasizes the issues (proper timing, concomitant immunossupression, source and immunogenicity of mesenchymal stem cells, and oncogenicity) that have been addressed and will be followed up by the MiSOT Consortium in future studies.Entities:
Mesh：
Year: 2013 PMID： 23759879 PMCID： PMC3737392 DOI： 10.1097/TP.0b013e318298f9fa
Source DB: PubMed Journal: Transplantation ISSN： 0041-1337 Impact factor: 4.939